Gonadotropin‐releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta‐analysis

Publisher： John Wiley & Sons Inc

E-ISSN： 1469-0705|51|1|77-86

ISSN： 0960-7692

Source： ULTRASOUND IN OBSTETRICS & GYNECOLOGY, Vol.51, Iss.1, 2018-01, pp. : 77-86

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preservation of ovarian function and minimizing premature ovarian failure during chemotherapy using gonadotropin-releasing hormone analogs

By Blumenfeld Zeev  

Women's Health, Vol. 7, Iss. 6, 2011-11 ,pp. : 635-640

Future Medicine

Access to resources Recommend Favorite

The Role of Adjuvant Chemotherapy for Patients with Resected Pancreatic Cancer: Systematic Review of Randomized Controlled Trials and Meta-Analysis

By  

Oncology, Vol. 72, Iss. 5-6, 2008-01 ,pp. : 314-321

Karger

Access to resources Recommend Favorite

Non‐steroidal antiandrogen monotherapy compared with luteinizing hormone‐releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer: a Cochrane systematic review

By  

BJU INTERNATIONAL, Vol. 116, Iss. 1, 2015-07 ,pp. : 30-36

John Wiley & Sons Inc

Access to resources Recommend Favorite

Model of gonadotropin-releasing hormone and gonadotropin-releasing hormone complex

By Wiwanitkit Viroj  

Sexuality and Disability, Vol. 24, Iss. 3, 2006-09 ,pp. : 175-178

Springer Publishing Company

Access to resources Recommend Favorite

The risk of nail changes with taxane chemotherapy: a systematic review of the literature and meta‐analysis

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 3, 2015-09 ,pp. : 842-845

John Wiley & Sons Inc

Access to resources Recommend Favorite